Filter posts

Innovation Is… with David Pyott of Allergan, Inc

The term innovation is thrown around more often than Peyton Manning’s name during Fantasy Football …

Innovation Is… with Stephan Tanda, Managing Board Member, Royal DSM

The term “innovation” is thrown around more often than Peyton Manning’s name during Fantasy Football …

Innovative Companies and Investment Trends in Clean Tech at World Congress

A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 …

Roundtable Discussion Highlights Innovation, Commercial Reality for Renewable Chemical Products

Last week BIO brought together representatives from five renewable chemical companies that will be speaking …

Opening Up Innovation

Open Innovation has become a major theme in the life sciences over the last couple …

BayBio Op-ed featured in Xconomy

Gail Maderis, President & CEO of BayBio, recently discussed the strength of Northern California’s biotechnology …

National Bioeconomy Blueprint

Today, the White House released its National Bioeconomy Blueprint.  The Blueprint defines the bioeconomy as, …

The Real Reason Why Salk Refused to Patent the Polio Vaccine

Editor’s Note: Despite the progress in polio and other diseases made possible by vaccines, today …

Brazilian Innovation: A Patent Success

The story of Acheflan highlights the role of patents in homegrown innovation in developing countries.  …

Biomedical Innovation: How the U.S. Can Stay Number One

By Ross DeVol, chief research officer of the Milken Institute “The first step in winning …